Jan 19, 2021 8:03am EST Algernon Pharmaceuticals Receives Green Light from DSMB to Conduct Phase 3 Study of Ifenprodil for COVID-19
Jan 11, 2021 8:00am EST Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment
Dec 24, 2020 11:42am EST Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19
Dec 21, 2020 8:00am EST Algernon CEO and CSO to Discuss COVID-19 Study Interim Data Results Featured on Streetsmart Live! Webcast
Dec 17, 2020 8:00am EST Algernon Pharmaceuticals Provides Additional Information on Phase 2b/3 Ifenprodil COVID-19 Study Interim Data
Dec 16, 2020 7:43pm EST Algernon CEO and CSO to Discuss COVID-19 Interim Data Results Featured on BioPub Webcast Hosted by Dr. KSS MD PhD
Dec 15, 2020 8:15am EST Algernon Pharmaceuticals Announces Positive Trending Interim Data for its Phase 2b/3 Ifenprodil COVID Study
